Skip to main content
xMedica

Search

170 studies match these filters. Showing 76–100 of 170 studies

Search results
Registration numberStudyStatusPhaseEnrolmentSites / countriesStart yearLast updatedActions
NCT07830719Dose-finding Study of YMI024 to Assess Efficacy, Safety, and Tolerability in Adults With Stable Coronary Artery Disease and Elevated hsCRP

The purpose of this Phase 2b study is to investigate the efficacy in reducing systemic inflammation, safety, tolerability, and dose response of five doses of YMI024, as compared to placebo in adult participants with stable coronary artery disease (CAD) and residual inflammatory risk defined by eleva…

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 23 sites in total · contact listed

RecruitingPhase 2180target23 / 52026Oct 15, 2026
NCT07578116Adding Surgery and Radiation to the Usual Treatment for HER2-Positive Breast Cancer That Had Already Spread at Diagnosis

This phase III trial evaluates the effect of adding locoregional therapy (surgery and radiation) and metastasis-directed stereotactic body radiation therapy (SBRT) to standard systemic therapy following standard HER2-targeted systemic therapy, compared to standard systemic therapy alone, in treating…

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 59 sites in total · contact listed

RecruitingPhase 3562target59 / 12027Oct 13, 2026
NCT07667803A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM

This master study protocol, Study D7260C00015, covers 2 independent, pivotal studies, Study 1 and Study 2. Each study is a global, randomized, double-blind, parallel-group, multicenter, Phase III study to assess the efficacy and safety of elecoglipron compared with placebo adjunct to diet and exerci…

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 325 sites in total

RecruitingPhase 34,500target325 / 192026Oct 13, 2026
NCT07206056An Open-label Dose Escalation and Expansion, Followed by a Phase II Study of Tulmimetostat (DZR123) and JSB462 (Luxdegalutamide) in Patients With Progressive Metastatic Castrate Resistant Prostate Cancer (mCRPC) (TulmiSTAR-01)

This is a two-part, Phase I/II, open-label, global, multicenter study assessing the safety and efficacy of the combination of tulmimetostat (DZR123) and JSB462 (luxdegalutamide) versus standard of care in participants with progressive metastatic castrate resistant prostate cancer (mCRPC).

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 35 sites in total · contact listed

RecruitingPhase 1 / Phase 2188target35 / 142025Oct 9, 2026
NCT07165028A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

The main purpose of the SYNERGY-OUTCOMES study is to find out whether retatrutide and tirzepatide can prevent major adverse liver outcomes (MALO) in people with high-risk metabolic dysfunction-associated steatotic liver disease (MASLD). The study will enroll adults who have MASLD based on non-invasi…

✓ Contact✗ Claimed

Nearest site: El Dorado, Kansas, United States — 85 km away · 563 sites in total · contact listed

RecruitingPhase 34,500target563 / 342025Oct 8, 2026
NCT07296484Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

CAPTAIN-T2D will take place in two parts. Part 1 (Screening) will evaluate patients with type 2 diabetes and elevated cortisol risk factors for trial eligibility and the presence of elevated cortisol. Participants deemed eligible from Part 1 will be randomized to either clofutriben or placebo in the…

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 61 sites in total · contact listed

RecruitingPhase 21,500target61 / 12025Oct 6, 2026
NCT06237452VE303 for Prevention of Recurrent Clostridioides Difficile Infection

The overall objective of the RESTORATiVE303 study is to evaluate the safety and the Clostridioides difficile infection (CDI) recurrence rate at Week 8 in participants who receive a 14-day course of VE303 or matching placebo. The objectives and endpoints are identical for Stage 1 (recurrent CDI) and…

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 215 sites in total

RecruitingPhase 3852target215 / 242024Nov 13, 2026
NCT04181060Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

This phase III trial compares the effect of bevacizumab and osimertinib combination vs. osimertinib alone for the treatment of non-small cell lung cancer that has spread outside of the lungs (stage IIIB-IV) and has a change (mutation) in a gene called EGFR. The EGFR protein is involved in cell signa…

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 604 sites in total · contact listed

RecruitingPhase 3300target604 / 12020Nov 4, 2026
NCT07570316A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease

The main purpose of this study is to look at how efgartigimod affects thyroid function in adults with Graves' Disease (GD). The study will also check whether efgartigimod is safe and well tolerated. It will look at how efgartigimod is distributed and eliminated in the body, how it changes antibody l…

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 35 sites in total · contact listed

RecruitingPhase 3230target35 / 32026Nov 3, 2026
NCT07684144Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

The primary objective of this trial is to evaluate the long-term efficacy, safety, and tolerability of maridebart cafraglutide in participants with obesity and type 2 diabetes mellitus. Trial 20210182 is extension of trial 20210184 (NCT06858878).

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 45 sites in total

RecruitingPhase 3950target45 / 52026Oct 5, 2026
NCT07684235Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

The primary objective of this trial is to evaluate the long-term efficacy, safety, and tolerability of maridebart cafraglutide in participants with obesity or overweight. Trial 20250197 is an extension of trial 20210181 (NCT06858839).

✓ Contact✗ Claimed

Nearest site: Newton, Kansas, United States — 53 km away · 92 sites in total

RecruitingPhase 33,200target92 / 52026Oct 5, 2026
NCT06283966A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

This study will evaluate the effect of triple ICS/LAMA/LABA therapy with BGF MDI 320/14.4/9.6 μg on cardiopulmonary outcomes relative to LAMA/LABA therapy with GFF MDI 14.4/9.6 μg in a population with COPD and elevated cardiopulmonary risk.

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 922 sites in total

RecruitingPhase 35,250target922 / 372024Oct 2, 2026
NCT06876714ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab

This phase III trial compares 6 months of human epidermal growth factor receptor 2 (HER2)-targeted therapy to 12 months of HER2-targeted therapy for the treatment of HER2-positive (+) breast cancer in patients that had a pathologic complete response (pCR) after preoperative (neoadjuvant) chemotherap…

✓ Contact✗ Claimed

Nearest site: Kingman, Kansas, United States — 28 km away · 702 sites in total · contact listed

RecruitingPhase 31,524target702 / 22025Oct 2, 2026
NCT07564414A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight

This clinical study is testing how the study medicine CagriSema helps people living with obesity, with or without type 2 diabetes (T2D), lose weight. The purpose of the study is to find out how safe and effective CagriSema is for body weight loss in these participants. Participants will receive eith…

✓ Contact✗ Claimed

Nearest site: Newton, Kansas, United States — 53 km away · 303 sites in total

RecruitingPhase 32,500target303 / 192026Sep 30, 2026
NCT05102019Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II

To demonstrate the safety and effectiveness of the Shockwave Reducer for treatment of patients with refractory angina pectoris treated with maximally tolerated guideline-directed medical therapy who demonstrate objective evidence of reversible myocardial ischemia in the distribution of the left coro…

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 97 sites in total

RecruitingNot applicable380target97 / 32022Sep 30, 2026
NCT07817251Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema

The purpose of this clinical study is to look at the safety and tolerability of switching from semaglutide to CagriSema, for participants who have type 2 diabetes. All participants will get CagriSema, the treatment being tested. Participants will be in this clinical study for about 6 months.

✓ Contact✗ Claimed

Nearest site: Newton, Kansas, United States — 53 km away · 40 sites in total

RecruitingPhase 3210target40 / 12026Sep 30, 2026
NCT07624305A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)

The purpose of this study is to evaluate the efficacy, safety and tolerability of balcinrenone in fixed combination with dapagliflozin, compared with dapagliflozin, in patients with CKD Stage 3b and 4 (eGFR ≥ 15 to \< 45 mL/min/1.73 m2) administered orally once daily in addition to SoC. This is a p…

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 478 sites in total

RecruitingPhase 32,800target478 / 272026Sep 24, 2026
NCT06605404Pan-tumor MRD Study

The purpose of this observational study is to collect clinical information, blood, and tumor tissue samples from participants diagnosed with stage I, stage II, or operable stage III cancer in select solid tumors. The information collected will be used to develop tests to better understand cancer, fo…

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 47 sites in total · contact listed

Recruiting1,350target47 / 12025Sep 24, 2026
NCT06777368REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE

The purpose of this study is to generate clinical evidence on valve safety and performance in subjects treated by redo Transcatheter Aortic Valve Replacement (TAVR).

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 71 sites in total · contact listed

Recruiting225target71 / 12025Sep 24, 2026
NCT07326709A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease

The purpose is to assess safety and tolerability of votoplam and to determine whether votoplam slows disease progression in patients with early symptomatic Huntington's disease (HD) compared to the control arm. HTT227 - current compound code (former code is PTC518 from PTC Therapeutics), HTT227 is…

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 117 sites in total · contact listed

RecruitingPhase 3770target117 / 272026Sep 22, 2026
NCT06990867Optimizing Reperfusion to Improve Outcomes and Neurologic Function

The goal of this study is to evaluate the safety and efficacy of JX10 versus placebo in participants with Acute Ischemic Stroke (AIS) who present for care within 4.5 to 24 hours. The main question the study aims to answer are: 1. JX10 improves functional outcomes as measured by the modified Rankin…

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 104 sites in total · contact listed

RecruitingPhase 2 / Phase 3740target104 / 212025Sep 21, 2026
NCT05485961Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

This is a two-part, phase 2b and phase 3 combined prospective, interventional, multicenter, randomized, double-blind, placebo-controlled study. Part 1: Phase 2b is a dose-finding study for CSL300 vs placebo. Part 2: Phase 3 aims to assess the efficacy of CSL300 vs placebo on cardiovascular (CV) out…

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 566 sites in total · contact listed

RecruitingPhase 2 / Phase 33,110target566 / 352024Sep 21, 2026
NCT06423911Study of Olverembatinib (HQP1351) in Patients With CML-CP

Study comparing efficacy and safety of olverembatinib (investigational arm) vs. bosutinib (control arm) in patients with CML-CP (Part A). Study will also evaluate efficacy and safety of olverembatinib (single-arm) in CML-CP patients with T315I mutation (Part B). Patients who meet ELN 2025 failure c…

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 163 sites in total

RecruitingPhase 3333target163 / 162024Sep 15, 2026
NCT07779408Study to Assess Safety and Immunogenicity of an Egg-based H5N8 Influenza Vaccine at Multiple Dose Levels Adjuvanted With Matrix-M in Healthy Participants 18 Years of Age and Above.

The study aims to evaluate an egg-based H5N8 influenza vaccine up to 3 dose levels (low, medium, and high dose) given with or without adjuvant to see if the adjuvant improves vaccine effectiveness. The study will enroll healthy adults aged 18 years and over. Participants will receive 2 injections i…

✓ Contact✗ Claimed

Nearest site: Newton, Kansas, United States — 53 km away · 16 sites in total

RecruitingPhase 1 / Phase 2640target16 / 12026Sep 15, 2026
NCT06033274Global Multicenter Registry on Transcatheter TRIcuspid Valve RePLACEment

The field of transcatheter tricuspid valve replacement (TTVR) is rapidly emerging and data on this topic are scarce. Particularly, little is known about which patients are at greatest risk of procedural complications, such as the timing and onset of conduction disturbances necessitating permanent pa…

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 31 sites in total

Recruiting800target31 / 82023Sep 15, 2026

Filters

Clear all filters